RxDoctor Payments Data

April Beck

Family · Barnesville, GANPI 1215596606

Payments from drug & device makers

$666in general payments, 2019–2025

Across 43 payments — averaging $15.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$142
  • Novo Nordisk$128
  • AstraZeneca$94
  • Pfizer$64
  • Phathom Pharmaceuticals, Inc.$43
  • Otsuka America Pharmaceutical, Inc.$35
  • plus $162 from 7 others

What the payments were for

  • Food & beverage$666100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$666 in reported general payments places this provider in the 60th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$4,307
Medicare patients
38
Services billed
41

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide81$91,559
JardianceEmpagliflozin75$68,969
Trelegy ElliptaFluticasone/Umeclidin/Vilanter66$66,272
JanuviaSitagliptin Phosphate69$64,454
EliquisApixaban43$46,848
RybelsusSemaglutide46$44,089
XareltoRivaroxaban38$43,451
FarxigaDapagliflozin Propanediol45$29,869
TrulicityDulaglutide11$21,015
Breo ElliptaFluticasone/Vilanterol33$17,598
Advair HfaFluticasone Propion/Salmeterol35$16,179
LinzessLinaclotide18$15,048
MounjaroTirzepatide14$13,372
Atrovent HfaIpratropium Bromide11$9,023
Aimovig AutoinjectorErenumab-Aooe12$8,493

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$128$135,648127 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy$35$87,370110 claims
Boehringer IngelheimJardiance$31$68,96975 claims
PfizerEliquis$64$46,84843 claims
AstraZenecaFarxiga, Symbicort$94$36,41462 claims
AbbVieLinzess, Synthroid$16$16,39737 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,258 family providers in Georgia.

Other family in Barnesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →